NCT05389514 2025-11-20
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Temporarily not available
Clinical Trials
3 trialsNCT06090864 2025-10-20
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT03354390 2024-12-03
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1 Active not recruiting